Amanda Wright
Family Medicine · Norman, OKNPI 1891082749
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $3,082 of the $4,365 with a category attached, or 70.6%. 32 manufacturers reported payments, led by Merck at 38.7% of the total. 2025 is the largest year on record at $1,926, 3.0 times the $649 reported in 2019.
Across 178 payments — averaging $24.52 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Merck$2K
- AbbVie$622
- Lilly USA, LLC$361
- Novo Nordisk$298
- Amgen$193
- AstraZeneca$188
- plus $1K from 26 others
What the payments were for
- Travel & lodging$1,28329%
- Food & beverage$3,08271%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Merck | 15 | $1,688 |
| AbbVie(2 entities) | 41 | $622 |
| Lilly USA, LLC | 31 | $361 |
| Novo Nordisk | 19 | $298 |
| Amgen | 12 | $193 |
| AstraZeneca | 11 | $188 |
| Medtronic | 1 | $101 |
| Esperion Therapeutics, Inc. | 5 | $85 |
| Nevro Corp. | 2 | $71 |
| Idorsia Pharmaceuticals US Inc | 4 | $67 |
| Biosense Webster, Inc. | 1 | $62 |
| Axsome Therapeutics, Inc. | 3 | $61 |
| Boehringer Ingelheim | 3 | $53 |
| Exact Sciences | 3 | $51 |
| Azurity Pharmaceuticals, Inc. | 3 | $50 |
| GSK | 3 | $42 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $40 |
| Astellas Pharma US Inc | 2 | $39 |
| Sanofi-aventis U.S. LLC | 2 | $31 |
| Johnson & Johnson | 2 | $30 |
| Biohaven Pharmaceutical Holding Company Ltd. | 2 | $29 |
| Ascendis Pharma Endocrinology Inc | 1 | $26 |
| Lexicon Pharmaceuticals, Inc. | 1 | $24 |
| Corcept Therapeutics | 1 | $23 |
| Pfizer | 1 | $19 |
| Dexcom, Inc. | 1 | $19 |
| Ultragenyx Pharmaceutical Inc. | 1 | $19 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 1 | $16 |
| Bayer | 1 | $16 |
| Kowa Pharmaceuticals America, Inc. | 1 | $16 |
| Arbor Pharmaceuticals, Inc. | 1 | $13 |
| Teva Pharmaceuticals USA, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- LINQ II$101
How this compares
$4,365 in reported general payments places this provider in the 80th percentile of 1,730 family medicine providers in Oklahoma.
Other family medicine in Norman
- Lisa ConneryNorman$105K
- Alexander FrankOklahoma City$3.1M
- Stanley ShadidEdmond$363K
- Geoffrey PlumleeTulsa$297K
- Curtis HarrisAda$125K
- Melinda CailOklahoma City$122K
- Jose Maria Borrego AcostaOklahoma City$106K
- Michael RobinsonElk City$84K
- Kimberly HuttonTulsa$76K
- James BeebeMuskogee$66K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.